GSK has entered an agreement to acquire Canadian biotechnology company 35Pharma for $950 million in order to strengthen its pipeline of therapies for pulmonary hypertension and related cardiopulmonary ...
INDUS Holding AG reported solid preliminary financial results for 2025, achieving revenue of €1.74 billion and adjusted EBITA of €147.8 million despite challenging economic conditions. The results met ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する